← Glossary / Medications
Bone Health Glossary · Medications

Antiresorptive

Also called: antiresorptive medication

Evidence
✓ Established Science
Topic
Medications
Taught in
Tier 2 · Lesson 7
In plain English

What it means

Antiresorptive medications, like bisphosphonates and denosumab, slow down the cells that break down old bone, helping bone density rise over time.

Why it matters for your bones

Understanding how your medication works helps you make sense of your bone density scans and conversations with your prescriber.

Antiresorptive medications are one of the two main families of osteoporosis drugs. The other family, anabolics, builds new bone. Antiresorptives work differently: they slow down osteoclasts, the cells that break down old bone during normal remodeling. By quieting this removal process, the bone-building side of remodeling gets a chance to catch up, which over time raises bone density. Bisphosphonates and denosumab are the main examples of this drug family.

It's worth understanding what the density number on a scan actually reflects once you're on an antiresorptive. Part of the rise happens because remodeling slows down, letting existing bone finish mineralizing more completely — so the scan reads higher. This is a real effect and is linked to fewer fractures in studies of these drugs. But density alone doesn't tell the whole story; the architecture of bone and how quickly it turns over also matter for strength. Over many years, very heavily suppressed turnover is thought to be connected to rare atypical fractures, so both the benefits and this nuance are part of the honest picture.

If you're ever prescribed an anabolic agent like teriparatide, abaloparatide, or romosozumab, standard practice is to follow that time-limited course with an antiresorptive, since the bone gains from anabolics aren't self-sustaining on their own. Any decisions about starting, stopping, or switching between these medication types belong to your prescriber, who can weigh your individual risk factors and history.

Evidence

How sure is this?

The research behind this
Established Science

Graded Established Science: Supported by broad scientific consensus and decades of research. Read each study with its grade in mind. One study is a piece of the picture, not the whole of it.

3 peer-reviewed studies, free with an Academy login
Go deeper

Where the Academy teaches it

This page is the short version. The lessons teach it in full, with the context around it and a quiz to lock it in.

Quick answers

Questions people ask about this

Bone medications generally work in one of two ways: they either slow down the cells that break down old bone (antiresorptives), or they actively stimulate the cells that build new bone (anabolics). Which family your drug belongs to tells you a lot about what it can realistically do, and that's worth asking your prescriber about directly.

Read the full answer →

Osteoporosis generally can't be fully "reversed" back to young, healthy bone, but it can be meaningfully improved. The remodeling system that builds and removes bone is still working in osteoporosis — it's just shifted toward loss — so rebalancing it through loading, nutrition, hormones, and sometimes medication can help rebuild some density and strength over time.

Read the full answer →

That's a decision for you and your prescriber, not something OsteoStrong changes. Medication and mechanical loading work on different parts of the same system — your drug manages the chemical signalling of bone remodeling, while loading supplies a mechanical stimulus along with muscle, balance and coordination. They're meant to work alongside each other, not replace one another.

Read the full answer →

Stopping Prolia (denosumab) isn't a neutral event. Because it doesn't build up in your bones the way bisphosphonates do, its protective effect wears off once doses stop. This can lead to a rapid rebound in bone turnover and a risk of multiple vertebral fractures, sometimes within months — so this is a decision to make with your prescriber, not on your own.

Read the full answer →
Keep going

Related words

Bisphosphonate
Strong Clinical Evidence

Bisphosphonates are osteoporosis medications — like alendronate, risedronate, and zoledronic acid — that slow down…

Denosumab
Strong Clinical Evidence

Denosumab (Prolia) is a twice-yearly injection that blocks RANKL, a signal osteoclasts need to mature, slowing bone…

Anabolic bone agent
Strong Clinical Evidence

Anabolic bone agents are medications, like teriparatide, abaloparatide, and romosozumab, that stimulate the body to…

Bone remodeling
Established Science

Bone remodeling is the lifelong cycle where cells called osteoclasts remove old bone and osteoblasts build new bone…

Osteoclast
Established Science

Osteoclasts are the cells that break down old bone tissue, working alongside bone-building osteoblasts to constantly…

Drug holiday
Strong Clinical Evidence

A drug holiday is a temporary, prescriber-guided pause from a bisphosphonate medication after several years of use,…

Education only, not medical advice. Decisions about tests, medications and treatment belong with your own doctor. OsteoStrong does not diagnose, treat or cure any disease.

Keep learning

More ways in